1. Home
  2. RCKT vs WT Comparison

RCKT vs WT Comparison

Compare RCKT & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • WT
  • Stock Information
  • Founded
  • RCKT 1999
  • WT 1985
  • Country
  • RCKT United States
  • WT United States
  • Employees
  • RCKT N/A
  • WT N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • WT Investment Bankers/Brokers/Service
  • Sector
  • RCKT Health Care
  • WT Finance
  • Exchange
  • RCKT Nasdaq
  • WT Nasdaq
  • Market Cap
  • RCKT 1.3B
  • WT 1.5B
  • IPO Year
  • RCKT N/A
  • WT N/A
  • Fundamental
  • Price
  • RCKT $11.74
  • WT $10.83
  • Analyst Decision
  • RCKT Strong Buy
  • WT Buy
  • Analyst Count
  • RCKT 11
  • WT 9
  • Target Price
  • RCKT $50.27
  • WT $12.08
  • AVG Volume (30 Days)
  • RCKT 1.3M
  • WT 1.6M
  • Earning Date
  • RCKT 11-07-2024
  • WT 01-31-2025
  • Dividend Yield
  • RCKT N/A
  • WT 1.08%
  • EPS Growth
  • RCKT N/A
  • WT N/A
  • EPS
  • RCKT N/A
  • WT 0.31
  • Revenue
  • RCKT N/A
  • WT $407,884,000.00
  • Revenue This Year
  • RCKT N/A
  • WT $26.44
  • Revenue Next Year
  • RCKT $234,928.88
  • WT $8.55
  • P/E Ratio
  • RCKT N/A
  • WT $35.29
  • Revenue Growth
  • RCKT N/A
  • WT 23.04
  • 52 Week Low
  • RCKT $11.58
  • WT $6.55
  • 52 Week High
  • RCKT $32.53
  • WT $12.45
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 27.69
  • WT 46.24
  • Support Level
  • RCKT $11.58
  • WT $11.03
  • Resistance Level
  • RCKT $15.00
  • WT $11.91
  • Average True Range (ATR)
  • RCKT 0.82
  • WT 0.33
  • MACD
  • RCKT -0.09
  • WT -0.09
  • Stochastic Oscillator
  • RCKT 4.65
  • WT 14.22

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About WT WisdomTree Inc.

WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models, and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime.

Share on Social Networks: